Silo pharma advances ptsd drug spc-15 toward first-in-human trial with key safety study initiated at frontage laboratories

Clear regulatory path to clinical trials for intranasal ptsd therapy targeting multi-billion-dollar market clear regulatory path to clinical trials for intranasal ptsd therapy targeting multi-billion-dollar market
SILO Ratings Summary
SILO Quant Ranking